Valuation: Milestone Pharmaceuticals Inc.

Market Cap 161M 141M 130M 120M 226M 15.53B 231M 1.55B 611M 7.6B 605M 592M 26.18B P/E 2026 *
-1.27x
P/E 2027 * -1.16x
Enterprise Value 161M 141M 130M 120M 226M 15.53B 231M 1.55B 611M 7.6B 605M 592M 26.18B EV / Sales 2026 *
22.6x
EV / Sales 2027 * 5.46x
Free-Float
99.3%
Yield 2026 *
-
Yield 2027 * -

Last Transcript: Milestone Pharmaceuticals Inc.

1 day-4.44%
1 week-7.42%
Current month-11.57%
1 month-9.54%
3 months-43.57%
6 months-42.20%
Current year-41.34%
1 week 1.17
Extreme 1.17
1.32
1 month 1.17
Extreme 1.17
1.38
Current year 1
Extreme 1
2.34
1 year 1
Extreme 1
3.06
3 years 0.63
Extreme 0.6254
3.62
5 years 0.63
Extreme 0.6254
9.85
10 years 0
Extreme 0
27.95
Manager TitleAgeSince
Chief Executive Officer 59 2017-03-06
Director of Finance/CFO 53 2019-09-08
Compliance Officer 48 2026-02-09
Director TitleAgeSince
Director/Board Member 59 2017-06-30
Director/Board Member 60 2019-03-31
Director/Board Member 67 2020-09-30
Date Insider Type Main position Quantity % Market Cap.
6/10/26 Free

Director

77,000 0.0618%
6/10/26 Free

Chairman

77,000 0.0618%
6/10/26 Free

Director

77,000 0.0618%
Change 5-day change 1-year change 3-year change Capi.($)
-4.44%-7.42%-28.18%-65.45% 161M
-7.17%-4.39%+45.51%+79.00% 52.1B
+0.24%-1.54%+53.22%+71.85% 53.83B
+0.80%-6.31%+3.98%+423.29% 23.48B
-0.09%-0.01%-17.62%-14.67% 23.13B
-5.95%-2.58%+30.67%-9.58% 19.36B
-1.14%+0.03%+31.57%-30.42% 17.56B
-5.16%-7.00%+168.44%+306.37% 15.2B
-6.91%-5.83%+26.53%+636.97% 14.83B
+0.43%-1.03%+24.63%+191.40% 14.06B
Average -2.94%-3.10%+33.88%+158.87% 23.37B
Weighted average by Cap. -2.80%-2.36%+40.07%+143.96%

Financials

2026 *2027 *
Net sales 7.14M 6.24M 5.76M 5.31M 10.01M 688M 10.23M 68.86M 27.08M 337M 26.83M 26.24M 1.16B 29.53M 25.8M 23.81M 21.95M 41.37M 2.84B 42.29M 285M 112M 1.39B 111M 108M 4.79B
Net income -112M -98.25M -90.66M -83.57M -158M -10.83B -161M -1.08B -426M -5.3B -422M -413M -18.25B -129M -112M -104M -95.63M -180M -12.39B -184M -1.24B -488M -6.07B -483M -473M -20.89B
Net Debt - -
Logo Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc. is a Canada-based biopharmaceutical company. The Company is focused on the development and commercialization of cardiovascular medicines. Its lead product candidate, etripamil, is a potent rapid-onset calcium channel blocker that the Company designed and is developing as a rapid-onset nasal spray to be administered by patients. The Company is also focused on developing etripamil to treat paroxysmal supraventricular tachycardia, atrial fibrillation, and other cardiovascular indications.
Employees
38
Date Price Change Volume
26-07-17 US$1.185 -4.44% 1,571,529
26-07-16 US$1.240 -2.36% 755,489
26-07-15 US$1.270 -2.31% 760,229
26-07-14 US$1.300 +1.56% 868,386
26-07-13 US$1.280 0.00% 511,197
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
1.185USD
Average target price
6.333USD
Spread / Average Target
+434.46%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MIST Stock